Drugs / Orotic acid

Trials 2 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01620268 Jul 2012 → Jun 2018 Changzheng-Cinkate Terminated No outcome recorded
Phase not applicable1 trial
NCT00227058 Jan → Nov 2005 seasonal allergic rhinitis University of Mississippi Medical Center Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as orotic acid ClinicalTrials.gov intervention name — accepted as the source's own label NCT01620268
1

NCT00227058

Known as Acide orotique ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as Acido orotico ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as Animal galactose factor ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as NSC-9791 ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as Oropur ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as Orotyl ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Known as Whey factor ChEMBL registry synonym — accepted as the source's own label CHEMBL1235017
Modality Small molecule CHEMBL1235017